← FDA Drug Approvals (Drugs@FDA)
PREGABALIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2022-03-22
Drug application
- FDA Application #
ANDA215249- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PREGABALIN
- Generic name
- PREGABALIN
- Active ingredients
- PREGABALIN
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RUBICON RESEARCH
- Manufacturer
- Advagen Pharma Ltd.
- First approval
- 2022-03-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown